Survival rates of children with cancer continue to increase
The survival rate of children with cancer continues to rise, according to figures published by IKNL. Healthcare professionals and scientists at the Princess Máxima Center remain committed to curing even more children with cancer and improving the quality of life of children and survivors.
Compared to the period 1990-1999, the survival rate of children diagnosed with cancer in 2010 through 2018 is markedly higher. For diagnoses during the latter period, the survival rate was 84 percent, up from 74 percent in the 1990s.
‘It is good to see that survival in childhood cancer has continued to increase,’ Prof. Dr. René Medema, Chief Scientific Officer, says of the new IKNL figures. ‘In several forms of leukemia, such as AML and ALL, we see the largest increase thanks to a sum of many different improvements. But across the board, there are still too many children with an extremely poor prognosis: the most difficult-to-treat tumors remain. That is why it is so important to continue to join forces of healthcare professionals and researchers within the Netherlands, within Europe and worldwide. Only together can we achieve the breakthroughs needed to cure all children with cancer, with optimal quality of life.’
Following the new figures, pediatric oncologist dr. Wouter Kollen and pediatric neurosurgeon prof. dr. Eelco Hoving gave an interview to the AD newspaper. Among other things, they talked about the strides being made with immunotherapy for treatment of leukemia, how new technology lets doctors operate better, and approaches to permanently improve the quality of life of children and survivors.
IKNL’s full press release can be found here. The AD interview is here.
Utrecht Science Park start-up Beephonix grows with the help of student workers
Utrecht Science Park start-up Beephonix is growing with support from student workers via Topselect, using its patented microphone technology for hearing implants and drone detection.
Royal honour awarded to Anton Pijpers at his farewell
At his farewell, Anton Pijpers was appointed Officer in the Order of Orange-Nassau and received multiple distinctions recognizing his exceptional contributions to Utrecht University and the region.
In the media: Utrecht Science Park as a ‘powerhouse’ of the biotech sector
Following the proposed merger of Utrecht Science Park companies Genmab and Merus, several media outlets have published articles highlighting the strength of the Utrecht Science Park ecosystem. For example, the Financieele Dagblad discussed the “biotech powerhouse” and the importance of growth opportunities to ensure this knowledge remains in the Netherlands.
Utrecht Science Week anniversary edition a great success
The fifth edition of Utrecht Science Week was a resounding success! With more programs, locations, speakers, and visitors than ever before, we look back on an exciting week. The variety of programs and the diverse audience were wonderful to witness. This way, the groundbreaking research here at Utrecht Science Park isn’t kept behind closed doors, but is given the opportunity to inspire others.